Difference between revisions of "Part:BBa K771004"

Line 2: Line 2:
 
<partinfo>BBa_K771004 short</partinfo>
 
<partinfo>BBa_K771004 short</partinfo>
  
Membrane anchor 4, which consists of interacting PDZ domain and membrane protein Lgt. Membrane Anchor 4 is proved to constitutively dimerize with Membrane Anchor 3 and 5 [[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771002 BBa_K771002]].
+
Membrane anchor 4, which consists of interacting PDZ domain([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771103 BBa_K771103]), GBD domain([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771105 BBa_K771105]) and membrane protein Lgt([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771102 BBa_K771102]). Membrane Anchor 4 is proved to constitutively aggregate with Membrane Anchor 3 and 5(with and without VVD).
  
==Membrane Accelerator System==
+
==Overview: Membrane Scaffold System==
[[Image:Membrane_accelerator.jpg|300px|center]]
+
[[Image:12SJTU-MA1-MA6.jpg|500px|center]]
 +
Demonstration of the whole ''Membrane Scaffold'' device. Membrane Anchor 2, 3, 4, 5 consitutively aggregate while Membrane Anchor 1 and 6 only aggregate with constitutive cluster (Membrane Anchor 2, 3, 4, 5) when certain signal is present.
  
 +
==Backgroud==
  
All four membrane proteins are assembled together through interacting domains and ligands. Downstream enzymes are thus assembled.
+
===Constitutive Aggregation===
 +
[[Image:12SJTU-CA345.jpg|300px|center]]
  
It has been proved to work as expected by recruiting enzymes involved in Fatty Acid biosynthetic pathway.
+
Membrane Anchor 3 ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771003 BBa_K771003]and Membrane Anchor 4 constitutively aggregate through PDZ  domain([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771103 BBa_K771103]) and PDZ ligand ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771104 BBa_K771104]).
  
==Membrane Rudder System==
+
Membrane Anchor 4 ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771003 BBa_K771003]and Membrane Anchor 5 (with and without VVD) constitutively aggregate through GBD domain([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771105 BBa_K771105]) and GBD ligand ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771106 BBa_K771106]).
[[Image:12SJTU-MA1-MA6.jpg|500px|center]]
+
Demonstration of the whole ''Membrane Rudder'' device.  
+
  
  
===Related Biobrick===
+
==Design==
 +
[[Image:12SJTU_MA4.jpg|100px|center]]
 +
Membrane Anchor 4 could constitutively aggregate with Membrane Anchor 3 and Membrane Anchor 5 through interacting domain and ligand.
 +
 
 +
==Characterization==
 +
 
 +
To testify the constitutive aggregation of Membrane Anchor 3, 4 and 5, we conducted Fluorescence Complementation Assay.
 +
 
 +
In fluorescence complementation assay, proteins that are postulated to interact are fused to unfolded complementary fragments of EGFP and expressed in ''E.coli''. Interaction of these proteins will bring the fluorescent fragments within proximity, allowing the reporter protein to reform in its native three-dimensional structure and emit its fluorescent signal. EGFP was split into two halves, named 1EGFP([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771113 BBa_K771113]) and 2EGFP([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771114 BBa_K771114]) respectively. If there is interaction between two proteins which were fused with 1EGFP and 2EGFP, it is expected that fluorescence should be observed. Otherwise, no fluorescence could be observed.
 +
 
 +
===Membrane Anchor 3 and Membrane Anchor 4===
 +
 
 +
[[Image:12SJTU_splitegfp34.jpg|thumb|400px|center|Construction information. We fused split EGFP 1 and 2 to Membrane Anchor 4 and Membrane Anchor 3 to test whether Membrane Anchor 3 and Membrane Anchor 4 could constitutively aggregate. Proteins in control group are not expected to aggregate like in experimental group.]]
 +
 
 +
[[Image:12SJTU_splitegfp34r.jpg|thumb|400px|center|We coexpressed proteins in experimental group and control group respectively in ''E.coli''. After induction for 6 hours, bacteria samples were taken for fluorescence observation]]
 +
The result shows that Membrane Anchor 3 and Membrane Anchor 4 could constitutively aggregate through PDZ domain and ligand.
 +
 
 +
===Membrane Anchor 4 and Membrane Anchor 5 without VVD===
 +
[[Image:12SJTU_splitegfp45.jpg|thumb|400px|center|We fused split EGFP 1 and 2 to Membrane Anchor 4 and Membrane Anchor 5 without VVD to test whether Membrane Anchor 4 and Membrane Anchor 5 without VVD could constitutively aggregate. Proteins in control group are not expected to aggregate like in experimental group.]]
 +
 
 +
[[Image:12SJTU_splitegfp45r.jpg|thumb|400px|center|We coexpressed proteins in experimental group and control group respectively in ''E.coli''. After induction for 6 hours, bacteria samples were taken for fluorescence observation]]
 +
The result shows that Membrane Anchor 4 and Membrane Anchor 5 without GBD domain could constitutively aggregate through GBD domain and ligand.
 +
 
 +
==Application==
 +
 
 +
We recruired fatty acid biosynthetic pathway involving TesA([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771301 BBa_K771301]), FabG([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771302 BBa_K771302)]) , FabI([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771303  BBa_K771303]), FabZ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771304 BBa_K771304]) to put our membrane scaffold system into practice. Fatty Acid productivity is enhanced by 24 fold.
 +
 
 +
We constructed TesA with Membrane Anchor 2 (without MS2) ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771305 BBa_K771305]),FabG with Membrane Anchor 3,([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771306 BBa_K771306]), FabZ with Membrane Anchor 4 ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771307 BBa_K771307]), FabI with Membrane Anchor 4(without VVD )([https://parts.igem.org/wiki/index.php?title=Part:BBa_K771308 BBa_K771308]). Click into each part for more infomation.
 +
 
 +
[[Image:12SJTU-FATTYACID.png|400px|center]]
 +
 
 +
 
 +
 
 +
==Related Biobrick==
 
<br\>Membrabe Anchor 1([[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771001 BBa_K771001]])
 
<br\>Membrabe Anchor 1([[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771001 BBa_K771001]])
 
<br\>Membrabe Anchor 2([[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771002 BBa_K771002]])
 
<br\>Membrabe Anchor 2([[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771002 BBa_K771002]])
Line 23: Line 57:
 
<br\>Membrabe Anchor 5([[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771005 BBa_K771005]])
 
<br\>Membrabe Anchor 5([[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771005 BBa_K771005]])
 
<br\>Membrabe Anchor 6([[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771006 BBa_K771006]])
 
<br\>Membrabe Anchor 6([[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771006 BBa_K771006]])
 +
 +
 +
==Reference==
 +
 +
Dueber, J. E., G. C. Wu, et al. (2009). "Synthetic protein scaffolds provide modular control over metabolic flux." Nature biotechnology 27(8): 753-759.
 +
  
  

Revision as of 09:08, 29 September 2012

Membrane Anchor 4 : ssDsbA-PDZ Domain-LGT-GBD Domain

Membrane anchor 4, which consists of interacting PDZ domain(BBa_K771103), GBD domain(BBa_K771105) and membrane protein Lgt(BBa_K771102). Membrane Anchor 4 is proved to constitutively aggregate with Membrane Anchor 3 and 5(with and without VVD).

Overview: Membrane Scaffold System

12SJTU-MA1-MA6.jpg

Demonstration of the whole Membrane Scaffold device. Membrane Anchor 2, 3, 4, 5 consitutively aggregate while Membrane Anchor 1 and 6 only aggregate with constitutive cluster (Membrane Anchor 2, 3, 4, 5) when certain signal is present.

Backgroud

Constitutive Aggregation

12SJTU-CA345.jpg

Membrane Anchor 3 (BBa_K771003and Membrane Anchor 4 constitutively aggregate through PDZ domain(BBa_K771103) and PDZ ligand (BBa_K771104).

Membrane Anchor 4 (BBa_K771003and Membrane Anchor 5 (with and without VVD) constitutively aggregate through GBD domain(BBa_K771105) and GBD ligand (BBa_K771106).


Design

12SJTU MA4.jpg

Membrane Anchor 4 could constitutively aggregate with Membrane Anchor 3 and Membrane Anchor 5 through interacting domain and ligand.

Characterization

To testify the constitutive aggregation of Membrane Anchor 3, 4 and 5, we conducted Fluorescence Complementation Assay.

In fluorescence complementation assay, proteins that are postulated to interact are fused to unfolded complementary fragments of EGFP and expressed in E.coli. Interaction of these proteins will bring the fluorescent fragments within proximity, allowing the reporter protein to reform in its native three-dimensional structure and emit its fluorescent signal. EGFP was split into two halves, named 1EGFP(BBa_K771113) and 2EGFP(BBa_K771114) respectively. If there is interaction between two proteins which were fused with 1EGFP and 2EGFP, it is expected that fluorescence should be observed. Otherwise, no fluorescence could be observed.

Membrane Anchor 3 and Membrane Anchor 4

Construction information. We fused split EGFP 1 and 2 to Membrane Anchor 4 and Membrane Anchor 3 to test whether Membrane Anchor 3 and Membrane Anchor 4 could constitutively aggregate. Proteins in control group are not expected to aggregate like in experimental group.
File:12SJTU splitegfp34r.jpg
We coexpressed proteins in experimental group and control group respectively in E.coli. After induction for 6 hours, bacteria samples were taken for fluorescence observation

The result shows that Membrane Anchor 3 and Membrane Anchor 4 could constitutively aggregate through PDZ domain and ligand.

Membrane Anchor 4 and Membrane Anchor 5 without VVD

We fused split EGFP 1 and 2 to Membrane Anchor 4 and Membrane Anchor 5 without VVD to test whether Membrane Anchor 4 and Membrane Anchor 5 without VVD could constitutively aggregate. Proteins in control group are not expected to aggregate like in experimental group.
File:12SJTU splitegfp45r.jpg
We coexpressed proteins in experimental group and control group respectively in E.coli. After induction for 6 hours, bacteria samples were taken for fluorescence observation

The result shows that Membrane Anchor 4 and Membrane Anchor 5 without GBD domain could constitutively aggregate through GBD domain and ligand.

Application

We recruired fatty acid biosynthetic pathway involving TesA(BBa_K771301), FabG(BBa_K771302)) , FabI(BBa_K771303), FabZ(BBa_K771304) to put our membrane scaffold system into practice. Fatty Acid productivity is enhanced by 24 fold.

We constructed TesA with Membrane Anchor 2 (without MS2) (BBa_K771305),FabG with Membrane Anchor 3,(BBa_K771306), FabZ with Membrane Anchor 4 (BBa_K771307), FabI with Membrane Anchor 4(without VVD )(BBa_K771308). Click into each part for more infomation.

12SJTU-FATTYACID.png


Related Biobrick

<br\>Membrabe Anchor 1([BBa_K771001]) <br\>Membrabe Anchor 2([BBa_K771002]) <br\>Membrabe Anchor 3([BBa_K771003]) <br\>Membrabe Anchor 5([BBa_K771005]) <br\>Membrabe Anchor 6([BBa_K771006])


Reference

Dueber, J. E., G. C. Wu, et al. (2009). "Synthetic protein scaffolds provide modular control over metabolic flux." Nature biotechnology 27(8): 753-759.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 115
    Illegal AgeI site found at 1174
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 345
    Illegal BsaI site found at 795